[30P-am] Modalities, biomolecules, biologics/Targeting/Pharmacologically active compounds (incl. metabolites)/Structure-activity relationship

[30P-am105] Development of antimicrobial peptide foldamers containing cationic disubstituted amino acids.

○Takashi Misawa¹, Takahito Ito^1,2, Megumi Kurashima¹, Yosuke Demizu^1,2 (1. National Institute of health sciences, 2. Grad. Sch. Med. Life Sci., Yokohama city Univ.)